GLP-1 peptides like semaglutide and tirzepatide have produced 15 to 22 percent body weight loss in clinical trials, numbers that used to belong only to bariatric surgery
But for some individuals, it can take several months before weight loss accelerates at the maximum dose
We have also added Figure 6, which summarizes all the GHSR dimers, the effects of these dimers as discussed in the paper, along with possible neuroanatomical locations important for these dimers
336 The 2021 ACG position paper recommends rifaximin use in IBS-D due to its improvement of abdominal pain and stool consistency and reduction of global IBS symptoms
SIDE EFFECTS: WHAT TO EXPECT One of the most common side effects of GLP-1 drugs like Wegovy is gastrointestinal discomfort, including nausea, bloating, constipation, and diarrhoea
The real reason may be more than just eating too much